Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

Gland Pharma Product Launch

Gland Pharma received USFDA approval for Sugammadex Injection single-dose vials. The product has been successfully launched via its marketing partner.

Source

NSE filing, NSE: GLAND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Gland Pharma Ltd: key numbers

Share price
₹3,095.90
Market cap
₹51,086 Cr
Revenue (annual)
₹6,431 Cr
Net profit (annual)
₹1,027 Cr
P/E (TTM)
45.3×Sector 45.9×
Promoter holding
45.75%-6.02% QoQ
FII holding
10.36%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gland Pharma Ltd

All →

Other product launch announcements

All →